A European box of Pfizer's pneumococcal vaccine. Photo: Fred Tanneau/AFP via Getty Images

In a narrow 8-6 vote today, a federal vaccine advisory panel shot down its 2014 recommendation that all adults 65 and older get a pneumococcal vaccine called Prevnar 13. Instead, the panel said seniors should get the vaccine based on conversations with their clinicians.

Why it matters: Seniors can still get the shot, but the vaccine won't be universally recommended — to the dismay of the vaccine makers. Pfizer sells Prevnar 13, and the drug company's stock shot down 2% once investors learned of the vote.

Details: Several members of the Advisory Committee on Immunization Practices, part of the Centers for Disease Control and Prevention, said this vote was one of the most difficult they've encountered.

  • The current evidence, presented during today's meeting, shows the vaccine only had marginal benefits for adults 65 and older.
  • However, Prevnar 13 is still universally recommended for children younger than 2.

What they're saying: Because more children are taking the vaccine and fewer are getting sick with pneumococcus, fewer older adults are getting exposed and sick, the experts said.

  • Supplying Prevnar 13 for adults "is not where the public health bang for the buck is," and "we're diluting the message that vaccinating the children is important," said Paul Hunter, a committee member and public health official in Milwaukee who voted against the 2014 recommendation.

1 money thing: Prevnar 13 is Pfizer's best-selling drug. U.S. sales exploded in 2015 after the CDC's recommendation, and although insurance will still cover the pricey vaccine, sales would drop if fewer adults feel like they need to get it.

Go deeper

Americans reflect on Independence Day amid racism reckoning

A Black Lives Matter banner and a United States flag on the facade of the U.S. embassy building in Seoul, South Korea. Photo: Simon Shin/SOPA Images/LightRocket via Getty Images

America's leaders are rethinking how they view Independence Day, as the country reckons with the historic, unequal treatment of people of color during a pandemic which has disproportionately affected nonwhite Americans.

Why it matters: The country’s legacy of racism has come into sharp focus in the weeks of protests following the death of George Floyd while in Minneapolis police custody. From Confederate statues to Mount Rushmore, Americans are reexamining the symbols and traditions they elevate and the history behind them.

Updated 12 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Global: Total confirmed cases as of 7 p.m. ET: 11,031,905 — Total deaths: 523,777 — Total recoveries — 5,834,337Map.
  2. U.S.: Total confirmed cases as of 7 p.m. ET: 2,788,395 — Total deaths: 129,306 — Total recoveries: 790,404 — Total tested: 34,213,497Map.
  3. States: ICU beds in Arizona's hot spot reach near capacity.
  4. Public health: The states where face coverings are mandatory Fauci says it has been a "very disturbing week" for the spread of the coronavirus in the U.S.
  5. Economy: The economy may recover just quickly enough to kill political interest in more stimulus.
14 hours ago - Sports

Washington Redskins to review team name amid public pressure

Photo: Patrick McDermott/Getty Images

The Washington Redskins have announced they will be conducting a review of the team's name after mounting pressure from the public and corporate sponsors.

Why it matters: This review is the first formal step the Redskins are taking since the debate surrounding the name first began. It comes after weeks of discussions between the team and the NFL, the team said.